67 related articles for article (PubMed ID: 12453933)
41. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
42. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
[TBL] [Abstract][Full Text] [Related]
43. New perspectives on enigmatic vanilloid receptors.
Szallasi A; Di Marzo V
Trends Neurosci; 2000 Oct; 23(10):491-7. PubMed ID: 11006466
[TBL] [Abstract][Full Text] [Related]
44. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord.
Morisset V; Ahluwalia J; Nagy I; Urban L
Eur J Pharmacol; 2001 Oct; 429(1-3):93-100. PubMed ID: 11698030
[TBL] [Abstract][Full Text] [Related]
45. Anandamide: some like it hot.
Di Marzo V; Bisogno T; De Petrocellis L
Trends Pharmacol Sci; 2001 Jul; 22(7):346-9. PubMed ID: 11431028
[TBL] [Abstract][Full Text] [Related]
46. Cardiovascular pharmacology of anandamide.
Högestätt ED; Zygmunt PM
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):343-51. PubMed ID: 12052048
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.
Ralevic V; Kendall DA; Randall MD; Smart D
Life Sci; 2002 Oct; 71(22):2577-94. PubMed ID: 12354577
[TBL] [Abstract][Full Text] [Related]
48. Endovanilloid signaling in pain.
Di Marzo V; Blumberg PM; Szallasi A
Curr Opin Neurobiol; 2002 Aug; 12(4):372-9. PubMed ID: 12139983
[TBL] [Abstract][Full Text] [Related]
49. Endocannabinoids: a new class of vasoactive substances.
Randall MD; Kendall DA
Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoid modulation of peripheral autonomic and sensory neurotransmission.
Ralevic V
Eur J Pharmacol; 2003 Jul; 472(1-2):1-21. PubMed ID: 12860468
[TBL] [Abstract][Full Text] [Related]
51. Cellular signal transduction by anandamide and 2-arachidonoylglycerol.
Howlett AC; Mukhopadhyay S
Chem Phys Lipids; 2000 Nov; 108(1-2):53-70. PubMed ID: 11106782
[TBL] [Abstract][Full Text] [Related]
52. Current perspectives on the therapeutic utility of VR1 antagonists.
Valenzano KJ; Sun Q
Curr Med Chem; 2004 Dec; 11(24):3185-202. PubMed ID: 15579007
[TBL] [Abstract][Full Text] [Related]
53. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid.
Hillard CJ; Campbell WB
J Lipid Res; 1997 Dec; 38(12):2383-98. PubMed ID: 9458263
[TBL] [Abstract][Full Text] [Related]
54. New dawn of cannabinoid pharmacology.
Devane WA
Trends Pharmacol Sci; 1994 Feb; 15(2):40-1. PubMed ID: 8165721
[No Abstract] [Full Text] [Related]
55. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.
Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Waku K
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):51-6. PubMed ID: 8906545
[TBL] [Abstract][Full Text] [Related]
56. A role for the endogenous cannabinoid system in the peripheral control of pain initiation.
Calignano A; La Rana G; Loubet-Lescoulié P; Piomelli D
Prog Brain Res; 2000; 129():471-82. PubMed ID: 11098711
[No Abstract] [Full Text] [Related]
57. Recent advances in understanding of vanilloid receptors: a therapeutic target for treatment of pain and inflammation in skin.
Biro T; Acs G; Acs P; Modarres S; Blumberg PM
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):56-60. PubMed ID: 9487017
[TBL] [Abstract][Full Text] [Related]
58. Endogenous lipids that activate cannabinoid receptors. Formation and inactivation.
Di Tomaso E; Cadas H; Gaillet S; Beltramo M; Desarnaud F; Venance L; Piomelli D
Adv Exp Med Biol; 1997; 407():335-40. PubMed ID: 9321973
[No Abstract] [Full Text] [Related]
59. Hot channels in airways: pharmacology of the vanilloid receptor.
Hwang SW; Oh U
Curr Opin Pharmacol; 2002 Jun; 2(3):235-42. PubMed ID: 12020463
[TBL] [Abstract][Full Text] [Related]
60. Novel natural vanilloid receptor agonists: new therapeutic targets for drug development.
Sterner O; Szallasi A
Trends Pharmacol Sci; 1999 Nov; 20(11):459-65. PubMed ID: 10542446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
